We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+13.58%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62B
AUM Growth
+$4.39B
(+7.6%)
Cap. Flow
-$1.97B
Cap. Flow
% of AUM
-3.18%
Top 10 Holdings %
Top 10 Hldgs %
43.7%
Holding
1,103
New
130
Increased
284
Reduced
500
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$218M |
| 2 |
Parker-Hannifin
PH
|
+$155M |
| 3 |
Illumina
ILMN
|
+$80.7M |
| 4 |
Walt Disney
DIS
|
+$74.2M |
| 5 |
AZEK
The AZEK Co
AZEK
|
+$56.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$819M |
| 2 |
Meta Platforms (Facebook)
META
|
+$338M |
| 3 |
Microsoft
MSFT
|
+$131M |
| 4 |
Amazon
AMZN
|
+$106M |
| 5 |
Salesforce
CRM
|
+$93.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.29% |
| 2 | Communication Services | 16.35% |
| 3 | Consumer Discretionary | 16.22% |
| 4 | Healthcare | 12.62% |
| 5 | Financials | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Vistra
VST
$47.4B
| $14.7M | 0.02% |
561,759
-6,460
| -1% | -$158K |
|
277
Andersons Inc
ANDE
$2.22B
| $14.5M | 0.02% |
314,135
+32,190
| +11% | +$1.35M |
|
278
InMode
INMD
$880M
| $14.5M | 0.02% |
388,106
+46,556
| +14% | +$1.63M |
|
279
Valaris
VAL
$5.47B
| $14.5M | 0.02% |
230,129
+27,599
| +14% | +$1.66M |
|
280
Crocs
CROX
$6.55B
| $14.4M | 0.02% |
128,232
+13,474
| +12% | +$1.61M |
|
281
V2X
VVX
$2.65B
| $14.1M | 0.02% |
284,159
+134,304
| +90% | +$5.86M |
|
282
Popular Inc
BPOP
$11.1B
| $14.1M | 0.02% |
232,433
+24,045
| +12% | +$1.42M |
|
283
Ecovyst
ECVT
$1.14B
| $14.1M | 0.02% |
1,226,335
+398,883
| +48% | +$4.34M |
|
284
Savers
SVV
$1.88B
| $14M | 0.02% |
+590,659
| New | +$13.8M |
|
285
Travel + Leisure Co
TNL
$4.7B
| $14M | 0.02% |
346,353
-6,750
| -2% | -$260K |
|
286
Cabot Corp
CBT
$4.52B
| $13.7M | 0.02% |
205,031
+14,083
| +7% | +$1M |
|
287
California Resources
CRC
$4.62B
| $13.6M | 0.02% |
301,233
-33,887
| -10% | -$1.38M |
|
288
Pacira BioSciences
PCRX
$997M
| $13.6M | 0.02% |
340,169
+66,353
| +24% | +$2.74M |
|
|
HOLX
289
DELISTED
Hologic
HOLX
| $13.5M | 0.02% |
166,596
-2,712
| -2% | -$222K |
|
290
Quanex
NX
$1.01B
| $13.5M | 0.02% |
501,098
+52,997
| +12% | +$1.18M |
|
291
International Money Express
IMXI
$367M
| $13.3M | 0.02% |
544,244
+57,206
| +12% | +$1.4M |
|
292
Genpact
G
$5.76B
| $13.3M | 0.02% |
352,848
-7,485
| -2% | -$301K |
|
293
Tractor Supply
TSCO
$18B
| $13.2M | 0.02% |
299,505
-5,370
| -2% | -$246K |
|
294
StepStone Group
STEP
$3.82B
| $13.2M | 0.02% |
533,187
-18,407
| -3% | -$423K |
|
295
SouthState Bank Corp
SSB
$10.5B
| $13.2M | 0.02% |
199,850
+20,982
| +12% | +$1.4M |
|
296
Expedia Group
EXPE
$37.3B
| $12.9M | 0.02% |
117,930
-5,230
| -4% | -$513K |
|
297
Jazz Pharmaceuticals
JAZZ
$16.7B
| $12.6M | 0.02% |
101,873
+3,051
| +3% | +$410K |
|
298
Chemed
CHE
$7.22B
| $12.6M | 0.02% |
23,281
+2,994
| +15% | +$1.64M |
|
299
ICICI Bank
IBN
$108B
| $12.6M | 0.02% |
545,642
+178,905
| +49% | +$4.05M |
|
300
Knife River
KNF
$3.79B
| $12.5M | 0.02% |
+286,314
| New | +$12.1M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2023 Portfolio in Review
As of Q2 2023, Loomis, Sayles & Company held 1,103 positions worth $62B, up 7.6% from $57.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Loomis, Sayles & Company withdrew a net $1.97B in Q2 2023, closing 130 positions and reducing 500 holdings. Its most notable exit was Halozyme, an estimated $81.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Loomis, Sayles & Company opened a new position in The AZEK Co worth $66.1M.
- Loomis, Sayles & Company's largest Q2 2023 buy was The AZEK Co: 2,181,837 shares worth $66.1M.
- Loomis, Sayles & Company added most to Tesla in Q2 2023, an estimated $218M increase.
- Loomis, Sayles & Company's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $819M.
- Loomis, Sayles & Company fully exited Halozyme in Q2 2023, selling an estimated $81.3M.
- Loomis, Sayles & Company's ten largest holdings make up 44% of its $62B portfolio in Q2 2023.
- Loomis, Sayles & Company opened 130 new positions and closed 130 in Q2 2023.
- Loomis, Sayles & Company's portfolio value rose 7.6% quarter-over-quarter to $62B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.